Print
SARS-CoV-2 viral nucleoprotein antigen self-test
Description

InnoScreenTM COVID-19 Antigen Rapid Test

SARS-CoV-2 VIRAL NUCLEOPROTEIN ANTIGEN SELF-TEST 

COVID 19 RAT

The InnoScreenTM COVID-19 Antigen Rapid Test Device is an in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in nasopharyngeal swab, nasal swab and oropharyngeal swab specimens from individuals suspected of COVID-19

COVID 19 Cassette

 

  • The only Australian made COVID Antigen Test
  • TGA approved. ARTG 336146
  • Results in 15 minutes
  • Built-in assay control in each test
  • Room temperature storage of kits

Suitable for Nasopharyngeal, Oropharyngeal swab and Nasal Swabs

COVID 19 Swabbing

 

Video Demonstration 

 

Performance

A total of 1437 clinical specimens were collected in the study, including 638 nasopharyngeal swabs and 799 oropharyngeal swabs, to verify the performance of COVID-19 Antigen Rapid Test Device. 240 specimens were confirmed positive, and 1197 specimens were confirmed negative by RT-PCR. InnoScreenTM COVID-19 Antigen Rapid Test Device has relative sensitivity of 98.80% (95% CI: 93.47% to 99.97%) for patients post onset of symptoms between 0 to 7 days and relative sensitivity of 75.16% (95% CI: 67.64% to 81.70%) for asymptomatic patients and patients post onset of symptoms for more than 7 days. The overall specificity of InnoScreenTM COVID-19 Antigen Rapid Test Device is 99.25% (95% CI: 98.58%-99.66%).

 

Pack Insert

 

Proceedure Card

 

Ordering Information:

InnoScreenTM COVID-19 Antigen Rapid Test            Stock Code: SCOV-23/1           Pack Size: 20   

 

 

 

 

Reviews

There are yet no reviews for this product.